Tikoo A - Search Results

1

An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.

Kinross KM, Montgomery KG, Kleinschmidt M, Waring P, Ivetac I, Tikoo A, Saad M, Hare L, Roh V, Mantamadiotis T, Sheppard KE, Ryland GL, Campbell IG, Gorringe KL, Christensen JG, Cullinane C, Hicks RJ, Pearson RB, Johnstone RW, McArthur GA, Phillips WA. Kinross KM, et al. Among authors: tikoo a. J Clin Invest. 2012 Feb;122(2):553-7. doi: 10.1172/JCI59309. Epub 2012 Jan 3. J Clin Invest. 2012. PMID: 22214849 Free PMC article.

2

Physiological levels of Pik3ca(H1047R) mutation in the mouse mammary gland results in ductal hyperplasia and formation of ERα-positive tumors.

Tikoo A, Roh V, Montgomery KG, Ivetac I, Waring P, Pelzer R, Hare L, Shackleton M, Humbert P, Phillips WA. Tikoo A, et al. PLoS One. 2012;7(5):e36924. doi: 10.1371/journal.pone.0036924. Epub 2012 May 30. PLoS One. 2012. PMID: 22666336 Free PMC article.

3

Reconstitution of stratified murine and human oesophageal epithelia in an in vivo transplant culture system.

Croagh D, Cheng S, Tikoo A, Nandurkar S, Thomas RJ, Kaur P, Phillips WA. Croagh D, et al. Among authors: tikoo a. Scand J Gastroenterol. 2008;43(10):1158-68. doi: 10.1080/00365520802102489. Scand J Gastroenterol. 2008. PMID: 18609138

4

Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.

Clemons NJ, Wang DH, Croagh D, Tikoo A, Fennell CM, Murone C, Scott AM, Watkins DN, Phillips WA. Clemons NJ, et al. Among authors: tikoo a. Am J Physiol Gastrointest Liver Physiol. 2012 Dec 15;303(12):G1335-46. doi: 10.1152/ajpgi.00291.2012. Epub 2012 Oct 11. Am J Physiol Gastrointest Liver Physiol. 2012. PMID: 23064761 Free article.

5

A clue to the therapy of neurofibromatosis type 2: NF2/merlin is a PAK1 inhibitor.

Hirokawa Y, Tikoo A, Huynh J, Utermark T, Hanemann CO, Giovannini M, Xiao GH, Testa JR, Wood J, Maruta H. Hirokawa Y, et al. Among authors: tikoo a. Cancer J. 2004 Jan-Feb;10(1):20-6. doi: 10.1097/00130404-200401000-00006. Cancer J. 2004. PMID: 15000491

6

Treatment of Ras-induced cancers by the F-actin cappers tensin and chaetoglobosin K, in combination with the caspase-1 inhibitor N1445.

Tikoo A, Cutler H, Lo SH, Chen LB, Maruta H. Tikoo A, et al. Cancer J Sci Am. 1999 Sep-Oct;5(5):293-300. Cancer J Sci Am. 1999. PMID: 10526670

7

The minimal fragments of c-Raf-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype.

Fridman M, Tikoo A, Varga M, Murphy A, Nur-E-Kamal MS, Maruta H. Fridman M, et al. Among authors: tikoo a. J Biol Chem. 1994 Dec 2;269(48):30105-8. J Biol Chem. 1994. PMID: 7982912 Free article.

8

An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).

Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H. Tikoo A, et al. J Biol Chem. 1994 Sep 23;269(38):23387-90. J Biol Chem. 1994. PMID: 8089100 Free article.

9

The GTPase and Rho GAP domains of p190, a tumor suppressor protein that binds the M(r) 120,000 Ras GAP, independently function as anti-Ras tumor suppressors.

Wang DZ, Nur-E-Kamal MS, Tikoo A, Montague W, Maruta H. Wang DZ, et al. Among authors: tikoo a. Cancer Res. 1997 Jun 15;57(12):2478-84. Cancer Res. 1997. PMID: 9192829

10

G proteins, phosphoinositides, and actin-cytoskeleton in the control of cancer growth.

Maruta H, He H, Tikoo A, Vuong T, Nur-E-Kamal M. Maruta H, et al. Among authors: tikoo a. Microsc Res Tech. 1999 Oct 1;47(1):61-6. doi: 10.1002/(SICI)1097-0029(19991001)47:1<61::AID-JEMT6>3.0.CO;2-Y. Microsc Res Tech. 1999. PMID: 10506762 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters